» Authors » Helen I Keen

Helen I Keen

Explore the profile of Helen I Keen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 65
Citations 712
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mau A, Keen H, Hill C, Buchbinder R
Intern Med J . 2025 Jan; PMID: 39754748
Background: The Australian Rheumatology Association identified the use of imaging in patients with low back pain without indication of serious pathology as a low-value practice. Aims: To determine the appropriateness...
2.
Nossent J, Keen H, Preen D, Inderjeeth C
J Rheumatol . 2024 Dec; 52(3):219-225. PMID: 39681370
Objective: Our aim was to compare the incidence of malignancy and its effect on mortality between hospitalized patients with rheumatoid arthritis (RA) and controls. Methods: We conducted a population-level observational...
3.
Hoon E, Edwards J, Robinson P, Rowett D, Stocks N, Keen H, et al.
Aust J Gen Pract . 2024 Nov; 53(11):864-871. PMID: 39499846
Background And Objectives: This study aimed to understand how gout is currently managed in Australian primary care and to assess the level of interest in changing the delivery of care...
4.
Kortekaas M, Vanhaverbeke T, Keen H, Terslev L, Hammer H, DAgostino M, et al.
Rheumatology (Oxford) . 2024 Aug; 64(3):919-934. PMID: 39115887
Objectives: Recently, the HAND OA US Examination (HOUSE) inflammatory and structural damage scores were developed by the OMERACT US Working Group. However, the thumb base was not, or was only...
5.
Laslett L, Scheepers L, Antony B, Wluka A, Cai G, Hill C, et al.
JAMA . 2024 May; 331(23):1997-2006. PMID: 38776073
Importance: Knee osteoarthritis is disabling, with few effective treatments. Preliminary evidence suggested that krill oil supplementation improved knee pain, but effects on knee osteoarthritis remain unclear. Objective: To evaluate efficacy...
6.
Almutairi K, Inderjeeth C, Preen D, Keen H, Nossent J
Rheumatol Int . 2024 Apr; 44(6):1089-1099. PMID: 38615313
Background/objectives: Adverse drug reactions (ADRs) can result in morbidity, mortality, and higher healthcare costs. Given the limited information available on ADRs associated with antirheumatic medications, this study aims to analyse...
7.
Nossent J, Keen H, Preen D, Inderjeeth C
Int J Rheum Dis . 2024 Feb; 27(2):e15079. PMID: 38396352
Objective: Given limited regional data, we investigate the state-wide epidemiology, renal and patient outcomes for lupus nephritis (LN) in Western Australia (WA). Methods: Patients hospitalized with incident SLE (≥2 diagnostic...
8.
Sirotti S, Terslev L, Filippucci E, Iagnocco A, Moller I, Naredo E, et al.
Lancet Rheumatol . 2024 Jan; 5(8):e474-e482. PMID: 38251579
Background: The Calcium Pyrophosphate Deposition (CPPD) subgroup of the Outcome Measures in Rheumatology (OMERACT) Ultrasound working group was established to validate ultrasound as an outcome measure instrument for CPPD, and...
9.
Paramalingam S, Needham M, Mastaglia F, Keen H
Clin Exp Rheumatol . 2023 Oct; 42(2):351-357. PMID: 37877419
Objectives: There is growing interest in ultrasound (US) as an outcome measure in IBM. Our study aimed to determine the ability of B mode US and power Doppler (PD) to...
10.
Wang Y, Jones G, Keen H, Hill C, Wluka A, Kasza J, et al.
Lancet . 2023 Oct; 402(10414):1764-1772. PMID: 37839420
Background: Hand osteoarthritis is a disabling condition with few effective therapies. Hand osteoarthritis with synovitis is a common inflammatory phenotype associated with pain. We aimed to examine the efficacy and...